Generic, Authorized Generic Versions Of Abbott’s Trilipix Among Recent Launches

In recent generic drug developments, Mylan announced that it has launched versions of the cholesterol drug Trilipix and the birth control pill Nor-Q.D.

On July 15, Mylan Inc. said its U.S.-based subsidiary, Mylan Pharmaceuticals Inc., has launched a generic version of Abbott’s Trilipix (fenofibric acid delayed-release) 45 mg and 135 mg capsules.

Trilipix is indicated as an adjunct to diet in combination with a statin to reduce triglycerides and increase high-density lipoprotein cholesterol in patients with mixed dyslipidemia and coronary heart disease (CHD) or a CHD risk equivalent who are on optimal statin therapy to achieve their low-density lipoprotein cholesterol ...